(2E)-3-Ethoxyacrylic acid, 97.0%, 25g

1-(2-Bromo-ethyl)-4-methyl-benzene, 95.0%, 100mg

2,2,2-Trifluoroacetic acid compound with 7-azaspiro[3.5]nonane-2-carboxylic acid (1:1), 98%, 100mg

(R)-1-phenylethanamine (2S,3S,4R)-4-(benzo[d][1,3]dioxol-5-yl)-1-(tert-butoxycarbonyl)-2-(4-methoxyphenyl)pyrrolidine-3-carboxylate, 98%, 50mg

4,4,5,5-Tetramethyl-2-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-1,3,2-dioxaborolane, 97%, 250mg

1-Allyl-1-methylpyrrolidinium Bis(trifluoromethanesulfonyl)imide>98.0%(T)5g

L-Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-[(4-methylphenyl)diphenylmethyl]-, 96%, 25g

1-(2-Chloropyridin-4-yl)piperazine, 95.0%, 10g

(S)-(+)-1,3-Butanediol, 95.0%, 100g

1,2,5-Trimethyl-1h-pyrrole, 98%, 1g

(5E)-5-(2,4-dimethylbenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one, 95.0%, 5g

3-Bromophenyl-(2-methylbenzyl)ether, 97.0%, 25g

4-Fluoro-5-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 5g